A Feasibility Study of the Therapeutic Response and Durability of Short-term Androgen-targeted Therapy in Early Prostate Cancer Managed with Surveillance: The Therapeutics in Active Prostate Surveillance (TAPS01) Study

BACKGROUND: Active surveillance (AS) is a preferred management option for men with prostate cancer with favourable prognosis. However, nearly half of men on AS switch to treatment within 5 years, so therapeutic strategies to prevent or delay disease progression could be considered. The androgen rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett, Tristan, Pacey, Simon, Leonard, Kelly, Wulff, Jerome, Funingana, Ionut-Gabriel, Gnanapragasam, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051967/
https://www.ncbi.nlm.nih.gov/pubmed/35495285
http://dx.doi.org/10.1016/j.euros.2022.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051967/
https://www.ncbi.nlm.nih.gov/pubmed/35495285
http://dx.doi.org/10.1016/j.euros.2022.01.007

Ejemplares similares